Note: Ingredients listed on restricted chemical lists
EC/CAS
2451-62-9
Name of the chemical
1,3,5-Tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione (TGIC)
Concentration
N/A
General Information
Revision date
2015-12-14
Product name
PSM20002 SILVER 8437 POL. TGIC
CAS No.
2451-62-9
1.2.1 Relevant identified uses
Electrostatic coating for use in industrial plants
Manufacturer Name
Vitracoat Pinturas en Polvo s.a. de c.v
Emergency telephone
(52) 722 26 27000
Icons in SDS
Company Information
company name
Vitracoat Pinturas en Polvo s.a. de c.v
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
This material is considered hazardous by the OSHA Hazard Communication Standard ( 29 CFR 1910. 1200 ) Emergency overview Physical state: Solid. [Powder.] Odor: Odorless.
Signal word
WARNING! HARMFUL IF INHALED OR SWALLOWED. CAUSES EYE IRRITATION. MAY CAUSE ALLERGIC SKIN REACTION. MAY CAUSE RESPIRATORY
Hazard statements
TRACT AND SKIN IRRITATION. CONTAINS MATERIAL THAT CAN CAUSE TARGET ORGAN DAMAGE. POSSIBLE CANCER HAZARD CONTAINS MATERIAL WHICH MAY CAUSE CANCER, BASED ON ANIMAL DATA. Do not handle until all safety precautions have been read and understood. Obtain special instructions before use. Do not breathe
Precautionary statements
dust. Do not ingest. Use only with adequate ventilation. Do not eat, drink or smoke when using this product. Avoid contact with eyes, skin and clothing. Keep container tightly closed. Use personal protective equipment as required. Wash thoroughly after handling.
Potential Acute Health Effects
Inhalation Toxic by inhalation. Slightly irritating to the respiratory system. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion Toxic if swallowed. Skin Slightly irritating to the skin. May cause sensitization by skin contact. Eyes Severely irritating to eyes. Risk of serious damage to eyes.
Potential chronic health
effects Contains material that can cause target organ damage. Repeated or prolonged inhalation of dust may lead to chronic respiratory irritation. Once sensitized, a severe allergic reaction may occur when subsequently exposed to very low levels. Carcinogenicity Contains material which may cause cancer, based on animal data. Risk of cancer depends on duration and level of exposure. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Target organs Contains material which causes damage to the following organs: lymphatic system. Contains material which may cause damage to the following organs: lungs, the nervous system, upper respiratory tract, skin, eyes. Over-exposure signs/symptoms Inhalation Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion No specific data. Adverse symptoms may include the following: Skin Irritation, redness Adverse symptoms may include the following: Eyes pain or irritation watering redness
Medical Conditions Generally Aggravated by Exposure
Pre-existing skin disorders and disorders involving any other target organs mentioned in this SDS as being at risk may be aggravated by over-exposure to this product. overexposure See toxicological information (Section 11)